La Jolla, CA – According to filings with the U.S. Securities and Exchange Commission, Inhibrx Inc. is raising $40,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Mark Lappe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Inhibrx Inc. At Inhibrx, our mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions. Toward this goal, we have built a large and diverse pipeline with the potential to impact cancer, infectious disease and orphan diseases.

To learn more about Inhibrx Inc., visit http://inhibrx.com/

Contact:
Mark Lappe, Chief Executive Officer
858-795-1499
https://www.linkedin.com/in/mark-lappe-91a44615/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved